Peter J. McKinnon

Peter J. McKinnon

Auto-generated profile, based on publicly available information

Peter J. McKinnon

Center for Pediatric Neurological Disease Research, St. Jude Pediatric Translational Neuroscience Initiative, St. Jude Children’s Research Hospital

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2009 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
PMPeter J. McKinnon
Peter J. McKinnon

1 August 2004 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
PMPeter J McKinnon
Peter J McKinnon

28 October 2013 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
PMPeter J McKinnon
Peter J McKinnon

28 February 2012 in Annual Review of Pathology: Mechanisms of Disease
Verified
Journal Article
Closed access
PMPeter J McKinnon
Peter J McKinnon
Ataxia telangiectasia (A-T) results from inactivation of the ATM protein kinase. DNA-damage signaling is a prime function of this kinase, although other roles have been ascribed to ATM. Identifying the primary ATM function(s) for tissue homeostasis is key to understanding how these functions contribute to the prevention of A-T-related pathology. In this regard, because A-T is primarily a neurodegenerative disease, it is essential to understand how ATM loss results in degenerative effects on the nervous system. In addition to delineating the biochemistry and cell biology of ATM, important insights into the molecular basis for neurodegeneration in A-T come from a spectrum of phenotypically related neurodegenerative diseases that directly result from DNA-repair deficiency. Together with A-T, these syndromes indicate that neurodegeneration can be caused by the failure to appropriately respond to DNA damage. This review focuses on defective DNA-damage signaling as the underlying cause of A-T.

4 October 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SKSachin Katyal
Sachin Katyal
SESherif F El‐Khamisy
Sherif F El‐Khamisy
HRHelen R Russell
Helen R Russell
YLYang Li
Yang Li
LJLimei Ju
Limei Ju
PMPeter J McKinnon
Peter J McKinnon
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

27 June 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KOKenji E. Orii
Kenji E. Orii
YLYoungsoo Lee
Youngsoo Lee
NKNaomi Kondo
Naomi Kondo
PMPeter J. McKinnon
Peter J. McKinnon
The repair of DNA double-strand breaks (DSBs) occurs via nonhomologous end-joining (NHEJ) or homologous recombination (HR). These mechanistically distinct pathways are critical for maintenance of genomic integrity and organismal survival. Although inactivation of either pathway leads to embryonic lethality, here we show selective requirements for each DNA DSB repair pathway at different stages of mammalian nervous system development. DNA damage-induced apoptosis resulting from inactivation of HR (Xrcc2 deficiency) only occurred in proliferating neural precursor cells, whereas disruption of NHEJ (DNA ligase IV deficiency) mainly affected differentiating cells at later developmental stages. Therefore, these data suggest that NHEJ is dispensable for a substantial portion of early development because DSB repair during this period utilizes HR. Moreover, DNA damage-induced apoptosis required the ataxia telangiectasia mutated (Atm) kinase after disruption of NHEJ, but not HR, during neurogenesis. However, embryonic lethality arising from disruption of either repair pathway was rescued by loss of p53 and resulted in specific tumor types reflective of the particular DSB repair pathway inactivated. Thus, these data reveal distinct tissue- and cell-type requirements for each DNA DSB repair pathway during neural development and provide insights for understanding the contributions of DNA DSB responses to disease.